Touyun Biotech Group Limited (01332) Releases Monthly Return for 30 November 2025
Bulletin Express
Dec 02, 2025
Touyun Biotech Group Limited (01332) reported no changes in its authorized share capital for 30 November 2025, with the total remaining at HKD500 million, comprising 12.5 billion ordinary shares at a par value of HKD0.04 each.
The total number of issued shares remained unchanged at 2,805,952,149. No movement in treasury shares was recorded.
Under the share option schemes, 278.5 million options were initially outstanding under a scheme adopted on 2 June 2022, with 180.8 million options lapsed, leaving 97.7 million options outstanding. Other schemes showed no material changes in their respective outstanding share options.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.